Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Non-bailable warrants...

    Non-bailable warrants issued against Sterling Biotech directors in Rs 5,000 crore fraud case

    Written by Ruby Khatun Khatun Published On 2017-11-17T12:33:18+05:30  |  Updated On 2021-08-18T14:38:29+05:30

    New Delhi: A Delhi court issued open-ended non-bailable warrants against two directors of a Gujarat pharma firm in a Rs 5,000 crore money laundering probe case.


    Additional Sessions Judge Siddharth Sharma, who had earlier told the Enforcement Directorate (ED) not to let "the shark run away while you (ED) are busy in catching the small fish", issued warrants against Sterling Biotech Ltd (SBL) directors Nitin and Chetan Sandesara in a case.


    Read also: Sterling Biotech Case: Don't let shark run away for catching small fish, Court tells ED


    While pressing for the issuance of the warrants, special public prosecutor Nitesh Rana told the court that Chetan was likely to have left the country.


    In the same case, the Supreme Court had sent a co-accused, Delhi-based businessman Gagan Dhawan, to the two-day custody of the Enforcement Directorate (ED).


    The trial court had on November 7 directed the ED to consider making Dhawan an approver.


    "Don't let the shark run away while you are busy in catching the small fish... There must be some bank officials as well. Go after them as well," the judge had said, noting that Dhawan was the only accused arrested in the case so far.


    Dhawan, arrested on October 31, had facilitated the firm's directors in the purchase of several properties and helped in misusing and diverting the credit facilities of several bank loans totaling Rs 5,000 crore, the ED had alleged.


    The ED has registered the alleged bank fraud case against the firm SBL under sections of the Prevention of Money Laundering Act (PMLA).


    The accused are also being probed by the ED for allegedly bribing senior income tax department officials as part of an earlier criminal complaint. The agency had carried out searches against Dhawan and a former Congress MLA in Delhi in August.


    The CBI had recently booked Sterling Biotech, its Directors Chetan Jayantilal Sandesara, Dipti Chetan Sandesara, Rajbhushan Omprakash Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, Chartered Accountant Hemant Hathi, former Director Andhra Bank Anup Garg and other unidentified persons in connection with the alleged bank fraud case.


    The CBI has alleged that the company had taken loans of over Rs 5,000 crore from a consortium led by Andhra Bank which has turned into non-performing assets. The FIR has alleged that the total pending dues of the group companies were Rs 5,383 crore as on December 31, 2016.


    The ED had taken a cognizance of this FIR to file a money laundering case against them.


    Read also: CBI FIR against Sterling Biotech for Rs 5,000 cr loan default


    Read also: ED searches Gujarat pharma firm for alleged FEMA violations

    bank fraud CBI) Chetan Sandesara Directors Enforcement Directorate FIR Gagan Dhawan Gujarat firm Judge Siddharth Sharma money laundering case Nitin Sandesara Non-bailable warrants Prevention of Money Laundering Act public prosecutor Nitesh Rana SBL Sterling Biotech Ltd Supreme Court 
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      3.36% of about 82,600 drugs samples found to be substandard

      3.36% of about 82,600 drugs samples found to be substandard

      Apollo medical centre in Oman granted hospital status

      Apollo medical centre in Oman granted hospital status

      Aurobindo Pharma receives USFDA approval to manufacture ADHD drug

      Aurobindo Pharma receives USFDA approval to manufacture ADHD drug

      Calcutta HC sets aside Centers decision for strategic sale of Bengal Chemicals

      Calcutta HC sets aside Center's decision for strategic sale of Bengal Chemicals

      Ipca Lab Conferred With the CARE Award

      Ipca Lab Conferred With the CARE Award

      Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

      Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

      View All

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 27 May 2022 6:45 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
      verify here.

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
      X
      X